Home > Insider Trading > Filing (0001209191-23-056524)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1845459	Nkgen Biotech Inc.	NKGN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1519672	A James Graf	C/O Nkgen Biotech, Inc. 3001 Daimler Street Santa Ana CA 92705	Interim Cfo	No	Yes	No	No
1862622	Graf Acquisition Partners Iv Llc	1790 Hughes Landing Blvd., Suite 400 The Woodlands TX 77380		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-11-20	10	$2.94	10	No	4	P	Direct
Common Stock	Acquisiton	2023-11-21	13	$2.92	23	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,436,744	Indirect	By Graf Acquisition Partners IV LLC

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.895 to $2.98, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
James A. Graf is the managing member of Graf Acquisition Partners IV LLC. Mr. Graf has voting and investment discretion with respect to the securities held of record by Graf Acquisition Partners IV LLC.